Lamotrigine Tablet
Product Images NDC 70518-2343

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 70518-2343). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Lamotrigine 100 mg oral tablets packaging label showing quantity of 30 tablets. The label includes the NDC number 70518-2343-01 and repackager RemedyRepack Inc., Indiana, PA. Storage instructions are visible, and the manufacturer is noted as Unichem Labs Ltd., Goa, India.*
FDA Label Image

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01
Chemical structure diagram of lamotrigine, showing the arrangement of its atoms including chlorine (Cl) atoms and nitrogen-containing rings consistent with lamotrigine's molecular composition.*
FDA Label Image

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02
A Kaplan-Meier failure probability curve comparing Lamotrigine and Placebo over approximately 100 weeks. The y-axis shows failure probability as a percentage, while the x-axis denotes time in weeks. The graph includes censored data points marked along both curves.*
FDA Label Image

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03
A line graph depicting failure probability (%) over time (weeks) for Lamotrigine and Placebo groups in a clinical study. The x-axis represents weeks from 0 to 80, and the y-axis shows failure probability from 0% to 100%. Two lines show higher failure probability for Placebo compared to Lamotrigine, with censored data points marked.*
FDA Label Image

Fe2785fe E8f4 4861 9511 88ef16b7232b 789 2

Fe2785fe E8f4 4861 9511 88ef16b7232b 789 2
Lamotrigine tablets in various strengths and shapes are shown with their imprints. The 25 mg white tablet is oval with imprint "U 111"; the 100 mg white tablet is triangular with imprint "U 112"; the 150 mg white tablet is triangular with imprint "U 113"; and the 200 mg light blue tablet is triangular with imprint "U 114". All tablets are oral dosage forms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.